Clinical approach to treatable inborn metabolic diseases: an introduction
- PMID: 16763886
- DOI: 10.1007/s10545-006-0358-0
Clinical approach to treatable inborn metabolic diseases: an introduction
Abstract
In view of the major improvements in treatment, it has become increasingly important that in order for first-line physicians not to miss a treatable disorder they should be able initiate a simple method of clinical screening, particularly in the emergency room. We present a simplified classification of treatable inborn errors of metabolism in three groups. Group 1 includes inborn errors of intermediary metabolism that give rise to an acute or chronic intoxication. It encompasses aminoacidopathies, organic acidurias, urea cycle disorders, sugar intolerances, metal disorders and porphyrias. Clinical expression can be acute or systemic or can involve a specific organ, and can strike in the neonatal period or later and intermittently from infancy to late adulthood. Most of these disorders are treatable and require the emergency removal of the toxin by special diets, extracorporeal procedures, cleansing drugs or vitamins. Group 2 includes inborn errors of intermediary metabolism that affect the cytoplasmic and mitochondrial energetic processes. Cytoplasmic defects encompass those affecting glycolysis, glycogenosis, gluconeogenesis, hyperinsulinisms, and creatine and pentose phosphate pathways; the latter are untreatable. Mitochondrial defects include respiratory chain disorders, and Krebs cycle and pyruvate oxidation defects, mostly untreatable, and disorders of fatty acid oxidation and ketone bodies that are treatable. Group 3 involves cellular organelles and includes lysosomal, peroxisomal, glycosylation, and cholesterol synthesis defects. Among these, some lysosomal disorders can be efficiently treated by enzyme replacement or substrate reduction therapies. Physicians can be faced with the possibility of a treatable inborn error in an emergency, either in the neonatal period or late in infancy to adulthood, or as chronic and progressive symptoms--general (failure to thrive), neurological, or specific for various organs or systems. These symptoms are summarized in four tables. In addition, an extensive list of medications used in the treatment of inborn errors is presented.
Similar articles
-
[Inborn errors of metabolism in adults].Ann Endocrinol (Paris). 2009 Mar;70(1):14-24. doi: 10.1016/j.ando.2008.12.004. Ann Endocrinol (Paris). 2009. PMID: 19178907 French.
-
Proposal for a simplified classification of IMD based on a pathophysiological approach: A practical guide for clinicians.J Inherit Metab Dis. 2019 Jul;42(4):706-727. doi: 10.1002/jimd.12086. Epub 2019 Apr 24. J Inherit Metab Dis. 2019. PMID: 30883825
-
[Inborn errors of metabolism in adult neurology].Rev Neurol (Paris). 2013 Feb;169 Suppl 1:S63-9. doi: 10.1016/S0035-3787(13)70062-6. Rev Neurol (Paris). 2013. PMID: 23452774 Review. French.
-
[Clinical presentation of inborn metabolic diseases in the neonatal period].Arch Pediatr. 2012 Sep;19(9):953-8. doi: 10.1016/j.arcped.2012.06.008. Epub 2012 Aug 9. Arch Pediatr. 2012. PMID: 22877859 French.
-
Inborn errors of metabolism in infancy: a guide to diagnosis.Pediatrics. 1998 Dec;102(6):E69. doi: 10.1542/peds.102.6.e69. Pediatrics. 1998. PMID: 9832597 Review.
Cited by
-
Integration of metabolic and gene regulatory networks modulates the C. elegans dietary response.Cell. 2013 Mar 28;153(1):253-66. doi: 10.1016/j.cell.2013.02.050. Cell. 2013. PMID: 23540702 Free PMC article.
-
The Reciprocal Interplay between Infections and Inherited Metabolic Disorders.Microorganisms. 2023 Oct 12;11(10):2545. doi: 10.3390/microorganisms11102545. Microorganisms. 2023. PMID: 37894204 Free PMC article. Review.
-
Fumaric aciduria: an overview and the first Brazilian case report.J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15. J Inherit Metab Dis. 2010. PMID: 20549362 Review.
-
Neuromonitoring in Rare Disorders of Metabolism.Yale J Biol Med. 2021 Dec 29;94(4):645-655. eCollection 2021 Dec. Yale J Biol Med. 2021. PMID: 34970103 Free PMC article. Review.
-
Oxidative stress assessment by glutathione peroxidase activity and glutathione levels in response to selenium supplementation in patients with Mucopolysaccharidosis I, II and VI.Genet Mol Biol. 2019 Jan-Mar;42(1):1-8. doi: 10.1590/1678-4685-GMB-2017-0334. Epub 2019 Feb 14. Genet Mol Biol. 2019. PMID: 30776046 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources